Oppenheimer & Co. Inc. Has $1.60 Million Stake in FIGS, Inc. (NYSE:FIGS)

Oppenheimer & Co. Inc. raised its position in shares of FIGS, Inc. (NYSE:FIGS - Free Report) by 106.5% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 348,628 shares of the company's stock after purchasing an additional 179,763 shares during the quarter. Oppenheimer & Co. Inc. owned about 0.21% of FIGS worth $1,600,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. SG Americas Securities LLC boosted its position in shares of FIGS by 88.6% during the 1st quarter. SG Americas Securities LLC now owns 107,951 shares of the company's stock valued at $495,000 after purchasing an additional 50,720 shares in the last quarter. Sugar Maple Asset Management LLC lifted its stake in FIGS by 211.4% during the first quarter. Sugar Maple Asset Management LLC now owns 21,800 shares of the company's stock valued at $100,000 after purchasing an additional 14,800 shares during the last quarter. GAMMA Investing LLC boosted its holdings in FIGS by 585.8% during the first quarter. GAMMA Investing LLC now owns 6,536 shares of the company's stock worth $30,000 after buying an additional 5,583 shares in the last quarter. Pullen Investment Management LLC boosted its holdings in FIGS by 46.1% during the fourth quarter. Pullen Investment Management LLC now owns 112,236 shares of the company's stock worth $695,000 after buying an additional 35,434 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in FIGS by 18.2% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 256,344 shares of the company's stock worth $1,587,000 after buying an additional 39,462 shares during the last quarter. 92.21% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently commented on FIGS. Telsey Advisory Group reiterated a "market perform" rating and set a $5.00 price objective on shares of FIGS in a research report on Tuesday, May 13th. Barclays reaffirmed a "positive" rating on shares of FIGS in a research report on Tuesday, May 13th. Morgan Stanley decreased their price target on FIGS from $4.75 to $4.25 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Finally, The Goldman Sachs Group dropped their price target on FIGS from $4.25 to $3.75 and set a "sell" rating on the stock in a research note on Tuesday, April 22nd.

FIGS Price Performance

FIGS stock traded up $0.09 during midday trading on Friday, reaching $5.91. The stock had a trading volume of 10,483,385 shares, compared to its average volume of 2,680,326. FIGS, Inc. has a twelve month low of $3.57 and a twelve month high of $7.06. The firm has a market cap of $960.51 million, a price-to-earnings ratio of 591.49 and a beta of 1.22. The firm's fifty day simple moving average is $4.74 and its two-hundred day simple moving average is $5.05.

About FIGS

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.